BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34750021)

  • 21. An immunohistochemical study of neuroendocrine cells in gynecologic tumors.
    Ueda G; Shimizu C; Saito J; Inoue Y; Tanaka Y; Inoue M; Tanizawa O
    Int J Gynaecol Obstet; 1989 Jun; 29(2):165-72. PubMed ID: 2568293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
    Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
    Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
    Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
    Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space.
    Gale N; Poljak M; Zidar N
    Head Neck Pathol; 2017 Mar; 11(1):23-32. PubMed ID: 28247231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma.
    Setia N; Ahn S; Han HS; Park DY; Lauwers GY
    Hum Pathol; 2019 Dec; 94():64-70. PubMed ID: 31676362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
    Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
    Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
    Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification.
    Leskela S; Romero I; Rosa-Rosa JM; Caniego-Casas T; Cristobal E; Pérez-Mies B; Gutierrez-Pecharroman A; Santón A; Ojeda B; López-Reig R; Palacios-Berraquero ML; Andrada E; Montes S; Pastor F; Gomez MC; López-Guerrero JA; Poveda A; Palacios J
    Am J Surg Pathol; 2020 Jul; 44(7):982-990. PubMed ID: 32384322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium.
    Kolin DL; Costigan DC; Dong F; Nucci MR; Howitt BE
    Am J Surg Pathol; 2019 Mar; 43(3):389-398. PubMed ID: 30489318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemistry as a diagnostic aid in cervical pathology.
    McCluggage WG
    Pathology; 2007 Feb; 39(1):97-111. PubMed ID: 17365826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma.
    Schmoeckel E; Hofmann S; Fromberger D; Rottmann M; Luthardt B; Burges A; Jeschke U; Kirchner T; Lax SF; Mayr D
    Virchows Arch; 2019 May; 474(5):599-608. PubMed ID: 30734108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Many Uses of p53 Immunohistochemistry in Gynecological Pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual9 Meeting.
    Köbel M; Kang EY
    Int J Gynecol Pathol; 2021 Jan; 40(1):32-40. PubMed ID: 33290354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of the upper genital tract.
    Ip SM; Wong LC; Xu CM; Cheung AN; Tsang PC; Ngan HY
    Gynecol Oncol; 2002 Oct; 87(1):104-11. PubMed ID: 12468350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updates in diagnostic immunohistochemistry in endometrial carcinoma.
    Chiang S; Soslow RA
    Semin Diagn Pathol; 2014 May; 31(3):205-15. PubMed ID: 24951284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.
    Wada T; Ohishi Y; Kaku T; Aman M; Imamura H; Yasutake N; Sonoda K; Kato K; Oda Y
    Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primitive Neuroectodermal Tumors of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Study of 19 Cases.
    Chiang S; Snuderl M; Kojiro-Sanada S; Quer Pi-Sunyer A; Daya D; Hayashi T; Bosincu L; Ogawa F; Rosenberg AE; Horn LC; Wang L; Iafrate AJ; Oliva E
    Am J Surg Pathol; 2017 Jun; 41(6):761-772. PubMed ID: 28296680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection of human papillomavirus (HPV) and p53 over-expression in human female genital tract carcinoma.
    Anwar K; Nakakuki K; Imai H; Shiraishi T; Inuzuka M
    J Pak Med Assoc; 1996 Oct; 46(10):220-4. PubMed ID: 8961706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells: Differences Across Histologic and TCGA-based Molecular Subgroups.
    Pasanen A; Ahvenainen T; Pellinen T; Vahteristo P; Loukovaara M; Bützow R
    Am J Surg Pathol; 2020 Feb; 44(2):174-181. PubMed ID: 31651527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
    Talhouk A; McConechy MK; Leung S; Yang W; Lum A; Senz J; Boyd N; Pike J; Anglesio M; Kwon JS; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
    Cancer; 2017 Mar; 123(5):802-813. PubMed ID: 28061006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.